Lynk Pharmaceuticals Announces First Participants in Phase I Trial of LNK01004
HANGZHOU, China, July 29, 2022 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Lynk Pharmaceuticals'), an innovative clinical stage company, announced that it has completed dosing the first participant in the phase I clinical study in China for its self-developed, innovative drug LNK01004. This study is to evaluate the safety, tolerability, and pharmacokinetics of the LNK01004 ointment in...
Illumina Among First in the World to Receive Approval of Science-Based Net-Zero Target
The Science Based Targets initiative has validated Illumina's targets to reach Net-Zero greenhouse gas emissions by 2050 SINGAPORE, July 29, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today it is among the first group of companies worldwide to receive approval of its net-zero...
Lenstec SBL-3 multifocal intraocular lens for cataract surgery approved by FDA for sale in the US
Lenstec Inc. has announced that its SBL-3 IOL has been approved by the FDA. ST. PETERSBURG, Fla., July 29, 2022 /PRNewswire/ -- The Lenstec SBL-3 IOL (Segmented Bifocal Lens) is a next-generation asymmetric multifocal refractive IOL which provides patients with near, intermediate and distance vision. Its patented design allows for improved contrast sensitivity and minimized halo and glare (dysphotopsias)...
Bon Natural Life Limited Announces 2022 Half-Year Earnings Release Date and Webcast
Earnings to be released before market opens on Monday, August 1, 2022 XIAN, China, July 29, 2022 /PRNewswire/ -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, will issue its half-year earnings release for the reporting period ended March 31,...
Daewoong Pharmaceutical Co., Ltd. revs up the growth engine for Nabota, achieving the highest quarterly performance ever
- Daewoong Pharmaceutical Co., Ltd. achieved 293.8 billion won in sales and 33.6 billion won in operating revenue in the second quarter due to the growth of ethical drugs and Nabota. - A continuous increase in profitability is expected due to sales visualization of the new drug Fexuclue and Nabota's entry into...
China Jo-Jo Drugstores Reports Fiscal Year 2022 Financial Results
HANGZHOU, China, July 28, 2022 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced its financial results for the fiscal year ended March 31, 2022. Mr. Lei Liu, Chairman and CEO of Jo-Jo...
IMG Partners with bolt to Offer Device Protection to Travelers
INDIANAPOLIS, July 28, 2022 /PRNewswire/ -- International Medical Group® (IMG®), an award-winning global insurance benefits and assistance services company, has announced a new partnership with bolt, an international insurtech and leading provider of mobile device protection programs. IMG now offers Mobile Device Protection as an optional add-on when purchasing a plan within the...
Angel Yeast Showcases Latest Innovation in Fermentation Nutrients at Bio China 2022
JINAN, China, July 28, 2022 /PRNewswire/ -- Angel Yeast (SH600298), a globally listed yeast and yeast extract manufacturer, exhibited its latest products and solutions of fermentation nutrients at Bio China 2022, an expo on fermentation and biotechnology held in Jinan, Shandong province. During the mid-July expo, the company showcased an array of new...
Ubiquitome’s Liberty16 Pro ready to carve up next COVID wave
Faster mobile PCR test device helping business continuity CHICAGO, July 28, 2022 /PRNewswire/ -- Ubiquitome, which won through the United States' NIH RADx shark tank COVID innovation initiative in 2020 and got FDA emergency use authorisation together with Yale's School of Public Health, has developed an even faster COVID PCR testing tool. Liberty16 Pro It is revealing...
ILC Dover Announces Multi-compendial Water for Injection (WFI) for Growing Biotherapeutic and Cell & Gene Therapy Markets
NEWARK, Del., July 28, 2022 /PRNewswire/ -- ILC Dover LP ("ILC Dover" or the "Company"), specializing in innovative single-use solutions for biotherapeutics and pharmaceutical processing, announced the launch of Water for Injection (WFI) for the biotherapeutics market. Used for the preparation of media, buffers, and other ingredients for biopharmaceuticals and medical devices, this launch continues to expand ILC Dover's...
